Compare HYLN & PACB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HYLN | PACB |
|---|---|---|
| Founded | 2018 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Construction/Ag Equipment/Trucks | Biotechnology: Laboratory Analytical Instruments |
| Sector | Consumer Discretionary | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 631.3M | 521.8M |
| IPO Year | 2019 | 2010 |
| Metric | HYLN | PACB |
|---|---|---|
| Price | $3.90 | $1.31 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 1 | 3 |
| Target Price | ★ $5.00 | $1.67 |
| AVG Volume (30 Days) | 2.7M | ★ 6.4M |
| Earning Date | 05-12-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $3,475,000.00 | ★ $93,468,000.00 |
| Revenue This Year | $197.93 | $11.32 |
| Revenue Next Year | $301.97 | $12.14 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 130.28 | 3.04 |
| 52 Week Low | $1.56 | $1.07 |
| 52 Week High | $8.49 | $2.73 |
| Indicator | HYLN | PACB |
|---|---|---|
| Relative Strength Index (RSI) | 52.93 | 46.64 |
| Support Level | $1.79 | $1.27 |
| Resistance Level | $4.56 | $1.47 |
| Average True Range (ATR) | 0.21 | 0.10 |
| MACD | 0.08 | -0.00 |
| Stochastic Oscillator | 72.96 | 16.67 |
Hyliion Holdings Corp designs and develops power generators for stationary and mobile applications and provides R&D service. It provides solutions that enable clean, flexible, and affordable electricity production. The company focuses on delivering distributed power generators that can operate on various fuel sources to future-proof against an ever-changing energy economy. In addition to stationary power solutions, it focuses on mobile applications, including vehicles and marine technologies. Its products and services include: KARNO Power Modules which is a modular, fully enclosed, fuel-agnostic and fully integrated power generating solution.
Pacific Biosciences of California Inc is a biotechnology company focused on designing, developing, and manufacturing sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, resolve genetically complex problems. It operates in, one reportable segment: the development, manufacturing, and marketing of an integrated platform for genetic analysis. The majority of the company's revenue is derived from Americas, followed by Europe Middle East, and Africa and Asia-Pacific.